Skip to content Skip to footer
Palforzia: Benefits, Reviews, Info, Side Effects!
Rx Details
Palforzia
Peanut oral immunotherapy, AR101, Aimmune Therapeutics
Peanut (Arachis hypogaea) Allergen Powder-dnfp
Prescription
Allergen
Drugs
Prescription Only
reduces risk of severe allergic reactions to peanuts, helps build tolerance to peanut exposure, provides a structured treatment plan for peanut allergy, improves quality of life for individuals with peanut allergy, allows for increased dietary flexibility
Abdominal Discomfort, Abdominal Pain, Anaphylaxis, Chest Discomfort, Cough, Diarrhea, Dizziness, Dyspnea, Ear Pruritus, Erythema, Fatigue, Flushing, Headache, Lip Swelling, Nasal Congestion, Nausea, Oral Pruritus, Oropharyngeal Pain, Pruritus, Rhinorrhea, Sneezing, Throat Irritation, Tongue Swelling, Urticaria, Vomiting, Wheezing
Palforzia is an oral immunotherapy used to mitigate allergic reactions to peanuts in individuals with a confirmed peanut allergy. The treatment involves a structured dosing regimen that gradually increases over time. The dosing is divided into three phases: 1. **Initial Dose Escalation**: This phase is typically conducted under medical supervision in a healthcare setting. It involves administering small, increasing doses of Palforzia over a single day. 2. **Up-Dosing**: This phase consists of 11 dose levels, starting from 3 mg and increasing up to 300 mg. Each dose level is usually administered daily for two weeks before moving to the next higher dose, provided the patient tolerates it well. The up-dosing phase is also often monitored by healthcare professionals. 3. **Maintenance**: Once the 300 mg dose is reached and tolerated, the patient enters the maintenance phase, where they continue to take 300 mg of Palforzia daily. It’s important to note that the exact dosing schedule and adjustments should be determined by a healthcare provider based on the individual’s response and tolerance to the treatment.
Peanut allergy
Palforzia has a generally safe safety profile.
No Interactions Reported
$850 – $950
$89,000.00

A Synopsis of

Palforzia

Palforzia is a groundbreaking medication that has been approved by the FDA for the treatment of peanut allergies in children and adolescents. This oral immunotherapy is designed to help individuals build up a tolerance to peanuts over time, reducing the risk of severe allergic reactions.

The way Palforzia works is by exposing the individual to small, controlled doses of peanut protein, gradually increasing the amount over time. This process helps the body develop a desensitization to peanuts, allowing for a higher threshold of tolerance.

It is important to note that Palforzia is not a cure for peanut allergies, but rather a management tool to help reduce the severity of allergic reactions. It is meant to be used in conjunction with a strict avoidance of peanuts in the diet and should only be administered under the supervision of a healthcare professional.

As with any medication, there are potential side effects to be aware of when taking Palforzia. These may include gastrointestinal symptoms, such as abdominal pain, vomiting, or diarrhea, as well as allergic reactions. It is crucial to discuss any concerns or potential side effects with your healthcare provider before starting treatment.

Overall, Palforzia offers hope for individuals with peanut allergies by providing a way to potentially reduce the risk of severe reactions. If you or your child has been diagnosed with a peanut allergy, I encourage you to speak with your healthcare provider about whether Palforzia may be a suitable treatment option for you.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN